Mizuho cuts target for Alcon stock from USD 85.00 to USD 80.00

Published on 10/14/2026 at 12:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mizuho cuts its target from USD 85.00 to USD 80.00 on October 13, 2026. Alcon stock costs EUR 57.39 at Lang & Schwarz on October 14, 2026.

Analyst targets and quarterly growth

Mizuho cut its Alcon target from USD 85.00 to USD 80.00 on October 13, 2026.
Alcon reported USD 2.823 billion in second-quarter 2026 revenue against USD 2.596 billion a year earlier.
Alcon stock traded at EUR 57.39 at 12:03 p.m. CEST at Lang & Schwarz on October 14, 2026.

Watercolor illustration of a stylized human eye centered in wide panoramic composition. Iris rendered in intricate pastel rainbow patterns in lavender, mint, peach, gold with delicate ink linework and translucent watercolor washes — Alcon CH0432492467: Aquarell Illustration eines Auges mit bunten Iris Mustern in zarten Pastellfarben, Illustration mit AI erstellt.

Alcon (CH0432492467) traded at EUR 57.39 at Lang & Schwarz at 12:03 p.m. CEST on October 14, 2026. Markets Insider reported on October 13, 2026 that Mizuho had cut its Alcon price target from USD 85.00 to USD 80.00 while retaining an Outperform rating. The target revision gives the latest analyst action a clear earnings-preview angle.

Analyst targets turn cautious

Mizuho cited procedure-volume headwinds linked to changes involving the Affordable Care Act and Medicaid. The same report said the target adjustment covered the medical devices and diagnostics group ahead of third-quarter results, making the November reporting date an important test of demand assumptions.

Markets Insider reported on October 12, 2026 that BTIG had lowered its Alcon target from USD 82.00 to USD 74.00 while keeping a Buy rating. Two target cuts in consecutive sessions point to a sharper divide between long-term product potential and near-term procedure-volume risk.

What does quarterly growth show?

Alcon's second-quarter 2026 revenue reached USD 2.823 billion, up from USD 2.596 billion in the same quarter a year earlier, according to VCBeat. The USD 227.00 million increase shows that the company entered the second half with measurable top-line expansion, even as analysts now emphasize procedure volumes and public-program exposure.

Results date sets the next test

Yahoo Finance lists Alcon's third-quarter 2026 earnings announcement for November 10, 2026, with consensus earnings per share of USD 0.89. That date puts the latest target reductions against a concrete operating checkpoint rather than a purely technical stock discussion.

Price holds the market reference

The Lang & Schwarz quote stood at EUR 57.39 at 12:03 p.m. CEST on October 14, 2026. Alcon's investor-relations profile describes a business with more than 25,000 associates serving customers in more than 140 countries through its Surgical and Vision Care segments, according to Alcon. The combination of revenue growth and analyst caution makes the November release the next material gauge for the stock.

The further course of trading is shown by the continuously updated real-time quote of Alcon stock.